TrialNature medicine2024

Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.

Yara L Verschoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.